Delirium, Catatonia, and COVID-19

<p>This podcast offers a discussion on catatonia and delirium as well as treatments for their co-occurrence. Treatments discussed include benzodiazepines, amantadine, and memantine. We also address the management of COVID-19 delirium with antipsychotics.</p> <p>Faculty: Scott Beach, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC110"> <strong>Learn more about Premium Memberships here</strong></a></li> <li><strong><a href= "https://psychopharmacologyinstitute.com/publication/management-of-delirium-2593?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC110"> Earn 1 CME: Management of Delirium</a></strong></li> <li><a href= "https://psychopharmacologyinstitute.com/section/special-considerations-in-delirium-catatonia-and-covid-19-2593-5027?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC110"> <strong>Special Considerations in Delirium: Catatonia and COVID-19</strong></a></li> </ul>